Paper33658348
T cell epitope screening of Epstein-Barr virus fusion protein gB.
Chen H and 16 others. J Virol, 2021. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. T cell epitope screening of Epstein-Barr virus fusion protein gB. Papers, record 33658348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33658348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11018123 | Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases. | Annu Rev Microbiol | 2000 | https://conductscience.org/library/papers/11018123 | PubMed |
| 2 | 24146041 | CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response. | J Immunol | 2013 | https://conductscience.org/library/papers/24146041 | PubMed |
| 3 | 15744535 | The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. | Immunogenetics | 2005 | https://conductscience.org/library/papers/15744535 | PubMed |
| 4 | 23867012 | Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model. | Vaccine | 2014 | https://conductscience.org/library/papers/23867012 | PubMed |
| 5 | 26969667 | Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing. | Front Med | 2016 | https://conductscience.org/library/papers/26969667 | PubMed |
| 6 | 14662920 | Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers. | J Clin Microbiol | 2003 | https://conductscience.org/library/papers/14662920 | PubMed |
| 7 | 31209392 | Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma. | Nat Genet | 2019 | https://conductscience.org/library/papers/31209392 | PubMed |
| 8 | 30714987 | Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers. | J Clin Invest | 2019 | https://conductscience.org/library/papers/30714987 | PubMed |
| 9 | 28296763 | Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol. | Medicine (Baltimore) | 2017 | https://conductscience.org/library/papers/28296763 | PubMed |
| 10 | 17360652 | Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17360652 | PubMed |
| 11 | 23601786 | Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma. | Virology | 2013 | https://conductscience.org/library/papers/23601786 | PubMed |
| 12 | 21123379 | The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. | J Virol | 2011 | https://conductscience.org/library/papers/21123379 | PubMed |
| 13 | 1334711 | Epstein-Barr virus BCRF1 gene product (viral interleukin 10) inhibits superoxide anion production by human monocytes. | Lymphokine Cytokine Res | 1992 | https://conductscience.org/library/papers/1334711 | PubMed |
| 14 | 23209447 | The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. | PLoS Genet | 2012 | https://conductscience.org/library/papers/23209447 | PubMed |
| 15 | 17846036 | Clustal W and Clustal X version 2.0. | Bioinformatics | 2007 | https://conductscience.org/library/papers/17846036 | PubMed |
| 16 | 16549597 | Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. | J Exp Med | 2006 | https://conductscience.org/library/papers/16549597 | PubMed |
| 17 | 29292383 | Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. | Nat Microbiol | 2018 | https://conductscience.org/library/papers/29292383 | PubMed |
| 18 | 19647480 | Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant. | J Clin Virol | 2009 | https://conductscience.org/library/papers/19647480 | PubMed |
| 19 | 27198675 | Targeting of cancer neoantigens with donor-derived T cell receptor repertoires. | Science | 2016 | https://conductscience.org/library/papers/27198675 | PubMed |
| 20 | 30248160 | Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection. | PLoS Pathog | 2018 | https://conductscience.org/library/papers/30248160 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39346922 | Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice. | Front Immunol | 2024 | https://conductscience.org/library/papers/39346922 | PubMed |
| 38906867 | A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection. | Nat Commun | 2024 | https://conductscience.org/library/papers/38906867 | PubMed |
| 38793551 | Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics. | Viruses | 2024 | https://conductscience.org/library/papers/38793551 | PubMed |
| 36713430 | Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36713430 | PubMed |
| 35404082 | Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses. | J Virol | 2022 | https://conductscience.org/library/papers/35404082 | PubMed |
| 34834989 | Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses. | Viruses | 2021 | https://conductscience.org/library/papers/34834989 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33658348
GET https://conductscience.org/api/papers/v1/33658348/references?page=2